View this page in: 简体中文版
A look at current financial reporting issues
Drop in value and volume of deals in the M&A market of China pharmaceuticals and medical devices sector.
M&A in China’s medical device sector.
New health reform has been rolled out to accommodate the rising of residents income level and healthcare awareness.
In this year's survey, 89 pharmaceuticals & life sciences CEOs from 37 countries share their views on the impact of globalisation, technological change, talent and trust.
A new direction for real estate industry transformation
China has listed hospital information system construction as an important part of hospital reform since 2011, and HRP (Hospital Resource Planning) system can help hospital implement its management strategy
Chinese medical device manufacturers and US regulatory compliance
An evaluation and review of the M&A development of the global medical device.
Pharmaceuticals and life sciences industry related findings in the 19th Annual Global CEO Survey.